Correlation Between Candel Therapeutics and Acurx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and Acurx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and Acurx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and Acurx Pharmaceuticals LLC, you can compare the effects of market volatilities on Candel Therapeutics and Acurx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of Acurx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and Acurx Pharmaceuticals.
Diversification Opportunities for Candel Therapeutics and Acurx Pharmaceuticals
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Candel and Acurx is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and Acurx Pharmaceuticals LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acurx Pharmaceuticals LLC and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with Acurx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acurx Pharmaceuticals LLC has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and Acurx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Candel Therapeutics and Acurx Pharmaceuticals
Given the investment horizon of 90 days Candel Therapeutics is expected to generate 2.37 times more return on investment than Acurx Pharmaceuticals. However, Candel Therapeutics is 2.37 times more volatile than Acurx Pharmaceuticals LLC. It trades about 0.05 of its potential returns per unit of risk. Acurx Pharmaceuticals LLC is currently generating about -0.01 per unit of risk. If you would invest 198.00 in Candel Therapeutics on August 31, 2024 and sell it today you would earn a total of 272.50 from holding Candel Therapeutics or generate 137.63% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Candel Therapeutics vs. Acurx Pharmaceuticals LLC
Performance |
Timeline |
Candel Therapeutics |
Acurx Pharmaceuticals LLC |
Candel Therapeutics and Acurx Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Candel Therapeutics and Acurx Pharmaceuticals
The main advantage of trading using opposite Candel Therapeutics and Acurx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, Acurx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acurx Pharmaceuticals will offset losses from the drop in Acurx Pharmaceuticals' long position.Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Acurx Pharmaceuticals vs. Aerovate Therapeutics | Acurx Pharmaceuticals vs. Adagene | Acurx Pharmaceuticals vs. Acrivon Therapeutics, Common | Acurx Pharmaceuticals vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |